Boston Scientific Corp (MIL:1BSX)
€ 39.01 -0.17 (-0.42%) Market Cap: 58.43 Bil Enterprise Value: 67.05 Bil PE Ratio: 18.73 PB Ratio: 2.57 GF Score: 63/100

Boston Scientific Corp at Bernstein Strategic Decisions Conference Transcript

May 27, 2026 / 12:00PM GMT
Release Date Price: €44.71 (-10.06%)
Lee Hambright
Sanford C Bernstein & Co LLC - Analyst

All right. Hi, everybody.

Michael Mahoney
Boston Scientific Corp - Chairman of the Board, President, Chief Executive Officer

Morning, Lee.

Lee Hambright
Sanford C Bernstein & Co LLC - Analyst

Hi, everybody. I'm Lee Hambright, US medtech analyst at Bernstein. We're very pleased to kick off the strategic decision conference again with Boston Scientific. We've got Mike Mahoney, Chairman and CEO; and Ken Stein, Chief Medical Officer. Thanks so much guys for being here.

Michael Mahoney
Boston Scientific Corp - Chairman of the Board, President, Chief Executive Officer

Thank you for having us.

Lee Hambright
Sanford C Bernstein & Co LLC - Analyst

For those of you in the audience, if you have questions, we can -- you can enter them in the pigeon hole tool. I will try to work in as many as I can.

Mike, kicking off your 15th year at Boston Scientific and you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot